SHL Medical and Kindeva partner to enhance services for Molly® autoinjector platform

SHL Medical and Kindeva Drug Delivery have formed a strategic partnership to offer fill-finish and pre-validated final assembly services for SHL’s Molly® autoinjector at Kindeva’s Bridgeton and Maryland Heights facilities.

Molly®, a modular single-dose autoinjector, is designed to help pharma and biotech companies reduce upfront investment and accelerate development. The collaboration will streamline communication, simplify supply chains, and support faster project delivery.

By combining SHL’s device expertise with Kindeva’s end-to-end CDMO capabilities, the partnership aims to bring innovative therapies to patients more efficiently and effectively.

SHL Medical, a world-leading solutions provider of advanced drug delivery systems, and Kindeva Drug Delivery, a global CDMO and drug delivery expert, are partnering to offer fill finish and pre-validated final assembly services for SHL Medical’s Molly® autoinjector platform at Kindeva’s Bridgeton and Maryland Heights facilities.

Built on a modular platform technology, Molly® is a single-dose autoinjector developed to help pharma and biotech companies reduce initial investments and expedite development timelines.

This strategic partnership between SHL and Kindeva will enhance collaboration, resulting in faster project completion,  streamlined communication, and efficient delivery of drug products.

Being one of only a few CDMOs who can address a full end-to-end range of services in one geographic location, Kindeva contributes to simplified supply chains.

Markus Puusepp, SHL Medical’s Chief Growth Officer, commented on the collaboration: “We are excited to partner with Kindeva to further enhance the capabilities of our Molly® autoinjector platform. This partnership will allow us to provide our customers with more efficient and comprehensive solutions, ultimately accelerating the delivery of innovative therapies to patients worldwide.”

Milton Boyer, CEO of Kindeva, said of the partnership: “Our collaboration with SHL Medical ensures that more patients will have access to treatments for a variety of conditions. By offering an integrated solution at our Bridgeton & Maryland Heights facilities, we can streamline project timelines, ensuring the timely, efficient, and safe delivery of drug products. I’m proud that our partnerships continue to have a positive impact on patients’ lives around the globe.”